FDA approves first generic Strattera for the treatment of ADHD
31 May 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration has approved the first generic versions of Strattera (atomoxetine) to treat (ADHD) in pediatric and adult patients...